Introduction
Non-small cell lung carcinoma (NSCLC) is the most common cancer in the world. Moreover, nearly all lung cancers are environmentally induced and thus preventable. Inflammation-induced fibrosis is considered a risk factor for carcinogenesis in multiple organs wherever underlying diseases such as idiopathic pulmonary fibrosis, ulcerative colitis, and liver cirrhosis exist. [1] [2] [3] Pneumoconiosis is an occupational lung disease characterized by irreversible fibrous lesions like silicotic nodules or mixed dust fibrosis in the lung, resulting from the chronic inhalation of silica and silicates in dusty workplaces. 4, 5 However, many studies of silica and mortality from lung cancer are affected by confounding data because of exposure to other toxins; only a few reports outline the outcome of surgical treatment for NSCLC complicated by pneumoconiosis. We conducted this study to clarify the clinicopathological features and review the outcome of resection of NSCLC in patients with pneumoconiosis.
Materials and Methods

Patients
Between April 1988 and March 2000, 122 patients (98 men and 24 women, ranging in age from 43 to 84 years) with NSCLC underwent lung resection at Iwamizawa Rosai Hospital, Japan. Patients with evidence of metastasis to other organs and those who had undergone prior anticancer treatment were excluded. The clinicopathologic stage was determined according to the TNM classification system of the International Union Against Cancer. 6 Pneumoconiosis was diagnosed and categorized in patients with a definite occupational history, according to the International Labour Office (ILO) Classification of Radiographs of Pneumoconioses. 7 In
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Purpose. Lung cancer resection in patients with respiratory complications is associated with a high surgical risk and the operative indications are usually serious. Consequently, the long-term results are unclear. We aimed to clarify the validity of surgery for non-small cell lung cancer (NSCLC) in patients with pneumoconiosis. Methods. We reviewed the clinical and pathological data of 122 patients undergoing resection of NSCLC with pneumoconiosis (n = 34: group A) or without pneumoconiosis (n = 88: group B) to assess treatment outcomes and prognostic factors.
Results. Among the treatment factors, intraoperative blood loss was significantly greater in group A (723.2 ± 647.3 ml) than in group B (466.4 ± 450.7 ml) (P = 0.0067), although the operative times (207 ± 103.4 min vs 196.1 ± 53.5 min, respectively) and postoperative drainage period (8.3 ± 4.2 days vs 8.5 ± 5.7 days, respectively) did not differ significantly between the two groups (P = 0.9466 and P = 0.6355, respectively). Among the postoperative complications, the incidence of hemorrhage was significantly higher in group A (29.4%) than in group B (7.9%) (P = 0.0022). The 5-year survival rates did not differ significantly between the two groups, (45.9% and 55.7% for groups A and B respectively) (P = 0.9424).
Conclusions. The coexistence of pneumoconiosis does not adversely affect postoperative survival or the treatment of NSCLC, although it is associated with increased intraoperative blood loss and postoperative hemorrhage. Thus, if precautions are taken to minimize hemorrhage, surgery cannot be excluded as a treatment option for NSCLC in patients with pneumoconiosis.
this classification system, parenchymal lung abnormalities on chest radiographs are identified and radiographic severity is classified on a 12-point scale range from 0/− to 3/+ by comparing the radiographs with ILO standard films. The pneumoconiotic patients were followed up carefully by regular medical examinations in Iwamizawa Rosai Hospital. Follow-up consisted of chest computed tomography (CT) scans at least every 6 months, with other routine tests, including chest radiography and sputum cytology, done at least every 3 months. Finally, 34 (27.9%) patients (group A) with pneumoconiosis and 88 (72.1%) patients without pneumoconiosis (group B) were included in this study. The NSCLCs included squamous cell carcinoma (SCC) in 59 patients, adenocarcinomas in 59, and large cell carcinomas in 4. The patients with pneumoconiosis (group A) comprised 24 with SCC and 10 with adenocarcinoma. Of the 122 patients, 14 underwent pneumonectomy, 105 underwent lobectomy, and 3 underwent segmentectomy. We assessed pulmonary function preoperatively in all patients. Postoperatively, the chest drainage tube was removed when air leakage was not detected and the effusion from the tube was less than 100 ml in 24 h. Postoperative complications were defined as those occurring within 30 days of thoracotomy. Pneumonia was diagnosed by persistent lung infiltrate and purulent tracheal secretions confirmed by bacterial culture of the sputum. Acute respiratory failure was defined by the need for postoperative ventilatory support for longer than 24 h or reintubation for controlled ventilation. Prolonged air leakage was defined as air leakage persisting for longer 10 days. Pneumothorax was confirmed on chest radiograph or CT scan and required chest tube placement. Hemorrhage was defined as severe bleeding through the chest tubes, necessitating reoperation or red blood cell transfusion. Cardiovascular complications were defined as symptomatic cardiac arrhythmia, acute myocardial infarction (ECG and elevation of creatine phosphokinase), or unstable angina. Tracheostomy was performed when controlled ventilation was needed for 14 days or longer.
Statistical Analysis
The chi-squared test, Fisher's test, or the MannWhitney U-test were used to analyze the correlation between complications of pneumoconiosis and patient data including histopathologic findings. The KaplanMeier method was used to generate survival curves, and survival differences were analyzed with the log-rank test, based on the status of complication with pneumoconiosis. The percentage of predicted value of vital capacity (%VC), force expiratory volume in 1 second (FEV 1.0% ), operative time, intraoperative blood loss, and duration of drainage are expressed as averages with standard deviation. Probability values of less than 0.05 were regarded as significant. All analyses were performed using statistical analysis software (Statview J version 5.0; SAS Institute, Cary, NC, USA).
Results
Patients' Characteristics
The correlation between complications associated with pneumoconiosis and the clinical features of the two groups is shown in Table 1 . The average age was 69.1 ± 5.9 years (range 56-77) in group A and 65.1 ± 9.1 years (range 43-84) in group B. All 34 patients in group A were men whereas in group B, 64 were men and 24 were women. The differences in sex (P = 0.0007) and age (P = 0.0246) were significant, but their correlation with histological stage, T factor, N factor, type of operation, and surgery-related death were not. Squamous cell carcinoma was the most common histological type in group A (P = 0.0072).
Perioperative Results
According to the preoperative pulmonary function tests, the average %VC was 102.2% ± 18.3% (range 70.8%-146.9%) in group A and 105.7% ± 17.9% (range 40.2-97.7%) in group B (P = 0.2767), and the average FEV 1.0% was 66.1% ± 11.3% (range 40.2%-97.7%) in group A and 70.5% ± 11.5% (range 28.8%-97.6%) in group B (P = 0.0250) (Fig. 1) . Intraoperatively, the mean operative time was 207.8 ± 103.4 min (range 106-700 min) in group A and 196.1 ± 53.5 min (range 66-360 min) in group B (P = 0.9466), and the mean intraoperative blood loss was 723.2 ± 647.3 ml (range 45-3 083 ml) in group A and 466.4 ± 450.7 ml (range 50-2500 ml) in group B (P = 0.0067). Postoperatively (Table 2) , the mean duration of drainage was 8.3 ± 4.2 days (range 3-21 days) in group A and 8.5 ± 5.7 days (range 2-35 days) in group B (P = 0.6334) (Fig. 2) . The incidence of postoperative hemorrhage was higher in group A (29.4%) than in group B (7.9%) (P = 0.0022), but the incidence of other complications was similar in the two groups. In group A, reoperation was performed for postoperative hemorrhage in two patients, and in group B, reoperation was performed for postoperative hemorrhage in two patients and for bronchopleural fistula in two patients (P = 0.7595). Tracheotomy was performed for four patients in group A and five in group B (P = 0.2491). The complications associated with pneumoconiosis were related to preoperative pulmonary function (FEV 1.0% ), intraoperative blood loss, and postoperative hemorrhage, but not to surgery-related death. 
Long-Term Results
The overall survival rate was 52.5% at 5 years, with a median follow-up period of 29.5 months. The 5-year survival rates were 45.9% in group A and 55.7% in group B, without a significant difference between the groups (P = 0.9424) (Fig. 3) . We attempted to determine if pneumoconiosis contributed to the prognosis after surgical resection. The clinicopathologic features of 34 patients with pneumoconiosis (group A) were compared with those of another 34 patients (control group) selected as clinically matched controls from among the 88 group B patients. 8 The 5-year survival rates were 45.9% and 54.4% in group A and the control group, respectively, without significance (P = 0.9688). 
Discussion
Pneumoconiosis has never been proven as a cause of lung cancer; however, the possibility of causality in lung cancer complicated by pneumoconiosis has been gaining support. Some studies suggest that the k-ras mutation and p53 are related to NSCLC complicated by pneumoconiosis. 9 ,10 Yet, the treatment of NSCLC in patients with pneumoconiosis has not been well studied. 11 Moreover, lung cancer complicated by pneumoconiosis tends often to be excluded from the operative indications based on respiratory insufficiency and old age. Thus, we examined the clinicopathological features, perioperative findings, and long-term results after surgery in NSCLC complicated by pneumoconiosis.
Patients with pneumoconiosis tend to be much older than those without pneumoconiosis, mainly because the number of new patients diagnosed with pneumoconiosis is decreasing worldwide. As the average age of patients being diagnosed with pneumoconiosis increases, the indications for lung resection will decrease. The results of this study may determine the operative indications for NSCLC complicated by pneumoconiosis.
Scarano et al. 12 and Kojima 13 reported that SCC was the histological type of lung cancer complicated by pneumoconiosis in 78.8% and 54.5% of their patients, respectively. Similarly, SCC was confirmed in 70.6% of our patients with pneumoconiosis, suggesting that the inhalation of carcinogens may play a role of in the pathogenesis of SCC lung cancer.
An analysis of the perioperative complications revealed that intraoperative blood loss and postoperative hemorrhage were significantly greater in group A than in group B. Adhesion, emphysema of the lung, and severe anthracosis in the medulla lymph node all render manipulation difficult during surgery in pneumoconiotic patients. Conversely, the difference in the duration of drainage was not significant between the two groups, which suggests that it is important to close the air leakage hole carefully during the operation, to minimize the risk of operative complications. In the present series, the survival rates of groups A and B were not significantly different, suggesting that pneumoconiosis might not increase the surgical risk posed by either the patient's state of health or the biological features of the tumor. Fig. 3 . Kaplan-Meier analysis of the overall survival of patients with and those without pneumoconiosis (log-rank test, P = 0.9424) As a novel treatment for NSCLC, video-assisted thoracoscopic surgery (VATS) has been shown to reduce surgical stress. Unfortunately, VATS was not performed in any of the patients in this series, although the effectiveness of VATS for lung cancer with pneumoconiosis is debatable, given the severe adhesion caused by the pneumoconiosis. Nevertheless, a comparison of thoracotomy with VATS is now under way.
We conclude that pneumoconiosis is a likely causative factor for SCC of the lung. However, if precautions are taken to minimize hemorrhage, pneumoconiosis should not increase the risk of surgery or the malignant potential of tumors in patients with NSCLC.
